RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 133 - per page Next page
Order by
New cream formulation to manage the symptoms of atopic dermatitis. More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
25 and 50 mg diclofenac K film coated immediate release tablets More
Xclair is a cream, indicated for the management of radiation-induced dermatitis, including relief and management of the most common signs and symptoms such as pruritus, erythema, burning and pain. More
SALINUM™ is a saliva substitute, indicated for the relief of symptoms of dry mouth, or xerostomia. More
Using a lamellar structure as a delivery system, the Sulidin® Nimesulide LPS gel provides enhanced percutaneous penetration of Nimesulide and reduced yellow staining on the skin. LPS Technology worldwide patents are pending. More
conception aid, fertility cup More
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
25mg dosage strenght for the OTC market in film coated tablets More
Displaying 1..10 of 133 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2010 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us